Glanbia Kept at Buy as Berenberg Sees 'Clear Path' Toward Market Share Expansion; Price Target Up

12:13 PM EDT, 10/05/2026 (MT Newswires) -- Berenberg reiterated its buy rating for Glanbia (GL9.IR, GLB.L), saying it sees a "clear path" toward continued market share expansion for the nutrition and wellness company. "Our analysis of LLM-based discovery shows that Glanbia is a leader in AI visibility and brand perception, with its outlook compounded by ongoing structural tailwinds across all three of its businesses. This leads to attractive c5.8% annual organic growth to 2028, 250bp faster than its food and ingredients peer average," according to a Monday note. Analysts expect the company to deliver an EPS growth of 14% through 2028, driven by strong top-line growth and an estimated 40 basis-point annual adjusted EBITDA margin expansion. The stock's price target was increased to 24.30 euros from 22.60 euros. In addition, the research firm updated its Glanbia model for the first-half results and latest company commentary, and revised its margin assumptions through 2030. Berenberg also raised its 2026 adjusted EPS forecast by 6.8%, after "meaningful" upgrades to full-year guidance in the first half.